Analyst Conference Summaries

Biotechnology Investor Aids

Agios
AGIO

conference date: November 1, 2017 @ 5:00 AM Pacific Time

AML Therapies, Part 2: Agios and Immunogen [September 29, 2016 at Seeking Alpha]

2017
02/16/2017
May 4, 2017
August 8, 2017
Nov. 1, 2017
2016
02/18/16
05/05/2015
08/04/2016
11/03/2016

Agios (AGIO) is a clinical-stage biotechnology company specializing in cellular metabolism based therapies for leukemia and other cancers. Its lead product candidates are partnered with Celgene.

Agios Therapeutics web site


 

Search

More Analyst Conference Pages:

 AGEN
 ALNY
 ALXN
 AMAT
 AMD
 AMGN
 BIIB
 CELG
 EPZM
 GILD
 GLYC
 INO
 INTC
 ISRG
 MACK
 MCHP
 MRVL
 MYL.
 NVDA
 REGN
 SGEN
 XLNX
 XLRN

 

Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. We try not to make errors, but it is possible. This is investment journalism, not financial advice.

Copyright 2016 William P. Meyers